Head and neck oncology - 2010, part I

Otolaryngologia Polska

Volumn 64, Issue 3, 2010, Pages 136-146

  Myers, Eugene N ^a  

^a University of Pittsburgh School of Medicine   (United States)

Author keywords

Endoscopic assisted thyroidectomy; Endoscopic endonasal skull base surgery; Microvascular free tissue transfer; Nonsurgical treatment of cancer of the head and neck; Pet ct scanning; Robotic surgery; Selective neck dissection; Sentinel node biopsy

Indexed keywords

CANCER INVASION; CANCER STAGING; CLINICAL TRIAL; DISEASE MANAGEMENT; EDITORIAL; HEAD AND NECK TUMOR; HUMAN; LARYNGOSCOPY; METHODOLOGY; MICROSURGERY; ONCOLOGY; PATHOLOGY; SQUAMOUS CELL CARCINOMA;

CARCINOMA, SQUAMOUS CELL; CLINICAL TRIALS AS TOPIC; DISEASE MANAGEMENT; HEAD AND NECK NEOPLASMS; HUMANS; LARYNGOSCOPY; MEDICAL ONCOLOGY; MICROSURGERY; NEOPLASM INVASIVENESS; NEOPLASM STAGING;

EID: 77956843968     PISSN: 00306657     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0030-6657(10)70049-4     Document Type: Editorial

References (45)

1. Haddad R, Shin D. Recent advances in head and neck cancer. N Engl J Med 2008; 359: 1143-54.
2. Arglris A, Karamouzis M, Raben D, Ferris RL. Head and neck Cancer, the Lancet 2008; 371: 1695-708.
3. d'Souza G, Kreimer A, Viscidi R, al. E. Case-control study of human papillomavirus and oropharyngeal cancer. N Engl J Med 2007; 356: 1944-1956.
4. Nasman A, Attner P, Hammarstedt L, Du J, Eriksson M, Giraud G, et al. Incidence of human papillomavirus (HPV) positive tonsillar carcinoma in Stockholm, Sweden: an epidemic of viral-induced carcinoma? Int J Cancer 2009; 125: 362-66.
5. Cooper JS, Pajak TF, Forastiere AA, Jacobs J, Campbell BH, Saxman SB, et al. Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck. N Engl J Med 2004; 350(19): 1937-44.
6. Bernier J, Domenge C, Ozsahin M, Matuszewska K, Lefebvre JL, Greiner RH, et al. Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer. N Engl J Med 2004; 350(19): 1945-52.
7. Bonner J, Harari P, Giralt J, al e. Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck. N Engl J Med 2006; 354: 567-78.
8. Vermorken J, Trigo J, Hitt R, al. E. Open-label, uncontrolled, multicenter phase II study to evaluate the efficacy and toxicity of cetuximab as a single agent in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck who failed to respond to platinum-based therapy. J Clin Oncol 2007; 25: 2171-77.
9. Ferrara N. VEGF as a therapeutic target in cancer. Oncolog 2005; 69 (suppl 3): S11-S16.
10. Pignon J, Bourhis J, Domenge C, Designe L. Chemotherapy added to locoregional treatment for head and neck squamous cell carcinoma: three meta-analyses of updated individual data. Lancet 2000; 355: 949-55.
11. Gleich L, Li Y, Wang X, Stambrook P, Gluckman J. Variable genetic alterations and survival in head and neck cancer. Arch Otolaryngol Head Neck Surg 1999; 125: 949-52.
12. Hoffman H, Karnell L, Funk G, al. E. The National Cancer Data Base report on cancer of the head and neck. Arch Otolaryngol Head and Neck 1998; 124: 951-62.
13. Chen A, Halpern H. Factors predictive of survival in advanced laryngeal cancer. Arch Otolaryngol Head and Neck Surg 2007; 133: 1270-76.
14. Gourin C, Conger B. Shells W, Bilodeau P, Coleman T, Proubsky E. The effect of treatment on survival in patients with advanced laryngeal carcinoma. Laryngoscope 2009; 119(July): 1312-17.
15. Deganello A, Gallo O, DeCesare J, Benedetta Ninu M, Gitti G, de'Campora L, et al. Supracricoid partial laryngectomy as salvage surgery for radiation therapy failure. Head and Neck 2008; 30: 1064-71.
16. 2 laser in the management of supraglottic squamous cell carcinoma. Head and Neck 2009; 31(9): 1196-206.
17. Chen A, Pavluck A, Halpern M, Ward E. Impact of treating facilities' volume on survival for early-stage laryngeal cancer. Head and Neck 2009; 31(9): 1137-43.
18. Chen AY, Schrag NM, Halpern M, Stewart A, Ward EM. Health insurance and stage at diagnosis of laryngeal cancer: does insurance type predict stage at diagnosis? Arch Otolaryngol Head Neck Surg 2007; 133(8): 784-90.
19. Groome P, Schulze K, S K, al e. Explaining socioeconomic status effects in laryngeal cancer. Clin Oncol (R Coll Radiol) 2006; 18: 283-92.
20. Cohan D, Popat S, Kaplan S, Rigual N, T L, Hicks W. Oropharyngeal cancer: current understanding and management. Curr Opin Otolaryngol Head Neck Surg 2009; 17(2): 88-94.
21. Grant D, Hini M, Salassa J, Perry W, Hayden R, Casler J. Oropharyngeal cancer: A case for single modality treatment with transoral laser microsurgery. Arch Otolaryngol Head Neck Surg 2009; 135(12): 1225-30.
22. Fein D, Lee W, Amos W, al e. Oropharygeal carcinoma treated with radiotherapy: a 30 year experience. Int J Radiat Oncol Biol Phys 1996; 34(2): 289-96.
23. Henstrom D, Moore E. Olsen K. Kasperbauer J, McGree M. Transoral resection for squamous cell carcinoma of the base of the tongue. Arch Otolaryngol Head Neck Surg 2009; 135(12): 1231-38.
24. Cano E, Lai S, Caylakli F, Johnson J, Ferris R, Carrau R, et al. Management of squamous cell carcinoma of the base of the tongue with chemoradiation and brachytherapy. Head and Neck 2009; 31(11): 1431-38.
25. Jackson C. Primary carcinoma of the nasopharynx. A table of cases. JAMA 1901; 37: 371-77.
26. Al-Sarraf M, LeBlanc M, PG G, al e. Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: Phase III randomized Intergroup study 0099. J Clin Oncol 1998; 16: 1310-17.
27. Yeo R, Fong K, Hee S, Chua, ET, Tan T, Wee J. Brachytherapy boost for T1/T2 nasopharyngeal carcinoma. Head and Neck 2009; 31(12): 1610-18.
28. Kim K, Wu H-G, Kim H, Sung M-W, Kim K, Lee S-H, et al. Intensity-modulated radiation therapy with simultaneous integrated boost technique following neoadjuvant chemotherapy for locoregionally advanced nasopharyngeal carcinoma. Head and Neck 2009; 31(9): 1121-28.
29. Wei W, Sham J. Cancer of the nasopharynx. In: Myers E, Suen J, Myers J, Hanna E, eds. Cancer of the Head and Neck, ed. 4th edition Philadelphia, PA: Saunders/Elsevier, 2003: 229-50.
30. Ko J-Y, Wang C-P, Ting L-L, Yang T-L, Tan C-T. Endoscopic nasopharyngectomy with potassium-titanyl-phosphate (KTP) laser for early locally recurrent nasopharyngeal carcinoma. Head and Neck 2009; 31(9): 1309-15.
31. Tan I, Nyst H, Sterenborg J, Van Veen R, Levendag P, Robinson D, et al. Photodynamic therapy (PDT) in nasopharyngeal cancer. In: Biel M, ed. Photodynamic therapy of diseases of the head and neck San Diego: Plural Publishing, 2008: 81-92.
32. Civantos F, Zitsch R, Bared A, Amin A. Sentinel node biopsy for squamous cell carcinoma of the head and neck. J Surg Oncol 2008; 97(8): 683-90.
33. Tannis P, Boom R, Koops H, al. E. Frozen section investigation of the sentinel node in malignant melanoma and breast cancer. Ann Surg Oncol 2001; 8: 222-26.
34. Chung C, Parker J, Yabrough W, al e. Molecular classification of head and neck squamous cell carcinoma using patterns of gene expression. Cancer Cell 2004; 5: 489-500.
35. Givi B, Andersen P. Rationale for modifying neck dissection. J Surg Oncol 2008; 97(8): 674-82.
36. Crile GW. On the surgical treatment of cancer of the head and neck. With a summary of one hundred and twenty-one operations performed upon one hundred and five patients. Trans South Surg Gynecol Assoc 1905; 18: 108-27.
37. Suarez O. El problema de las metastatis linfaticas y alejadas del cancer de laringe e hipofaringe. Rev Otorrinolaringol 1963; 23: 804-08.
38. Andersen P, Cambronera E, Shaha A, al. E. The extent of neck disease after regional failure during observation of th NO neck. Am J Surg 1996; 172: 689-91.
39. Byers RM. Modified neck dissection. A study of 967 cases from 1970 to 1980. Am J Surg 1985; 150(4): 414-21.
40. Andersen PE, Warren F, Spiro J, Burningham A, Wong R, Wax MK, et al. Results of selective neck dissection in management of the node-positive neck. Arch Otolaryngol Head Neck Surg 2002; 128(10): 1180-4.
41. Vedrine P-O, Thariat J, Hitier M, Janot F, Kaminsky M-C, Makeieff M, et al. Need for neck dissection after radiochemotherapy? A study of the French GETTEC Group. Laryngoscope 2008; 118: 1775-80.
42. Lango M, Andrews G, Ahmad S, Feigenberg S, Tuluc M, Gaughan J, et al. Postradiotherapy neck dissection for head and neck squamous cell carcinoma: pattern of pathologic residual carcinoma and prognosis. Head and Neck 2009; 31: 328-37.
43. van der Putten L, van den Broek G, de Bree R, van den Brekel M, Balm A. Hoebers F, et al. Effectiveness of salvage selective and modified radical neck dissection for regional pathologic lymphadenopathy after chemoradiation. Head and Neck 2009; 31(May): 593-603.
44. Mukhija V, Gupta S, Jacobson A, Anderson Eloy J, Genden E. Selective neck dissection following adjuvant therapy for advanced head and neck cancer. Head and Neck 2009; 31(February): 183-88.
45. Sewall G, Palazzi-Churas K, Richards G, Hartig G, Harari P. Planned postradiotherapy neck dissection: rational and clinical outcomes. Laryngoscope 2007; 117: 121-28.